Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-03

Clinical Trial Update: Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) [NA]

View source ↗

Summary

Completed clinical trial QUARTO III investigating lead and resynchronization therapy options for heart failure; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quartet Lead and Resynchronization Therapy (QUARTO_III)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | NA | Status: COMPLETED | Results posted: 2020-08-03